DICE Earnings & Financial Statements
DICE Therapeutics, Inc.
$22.99
-$0.15(-0.63%)
13
Overall
--
Value
9
Tech
18
Quality
Market Cap
$1.11B
Volume
381
52W Range
$23.55 - $26.16
Target Price
--
DICE earnings and financial statements: DICE Therapeutics, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
DICE Annual Financial Statements
| Fiscal year | 2022 | 2021 |
|---|---|---|
| Revenue | - | $1.13M |
| Operating income | -$88.22M | -$47.60M |
| EBITDA | -$85.53M | -$47.86M |
| Fiscal year | 2022 | 2021 |
|---|---|---|
| Cash and equivalents | $461.39M | $115.98M |
| Long-term debt | $11.84M | $1.92M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DICE | $22.99 | -0.6% | 381 |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |